156 related articles for article (PubMed ID: 19801833)
1. A possible mechanism underlying an antidepressive-like effect of Kososan, a Kampo medicine, via the hypothalamic orexinergic system in the stress-induced depression-like model mice.
Ito N; Yabe T; Nagai T; Oikawa T; Yamada H; Hanawa T
Biol Pharm Bull; 2009 Oct; 32(10):1716-22. PubMed ID: 19801833
[TBL] [Abstract][Full Text] [Related]
2. Involvement of neuropeptide Y signaling in the antidepressant-like effect and hippocampal cell proliferation induced by kososan, a Kampo medicine, in the stress-induced depression-like model mice.
Ito N; Hori A; Yabe T; Nagai T; Oikawa T; Yamada H; Hanawa T
Biol Pharm Bull; 2012; 35(10):1775-83. PubMed ID: 23037167
[TBL] [Abstract][Full Text] [Related]
3. Preventive effect of a Kampo medicine, kososan, on recurrent depression in a mouse model of repeated social defeat stress.
Ito N; Sasaki K; Hirose E; Nagai T; Isoda H; Odaguchi H
Gene; 2022 Jan; 806():145920. PubMed ID: 34455026
[TBL] [Abstract][Full Text] [Related]
4. I.c.v. administration of orexin-A induces an antidepressive-like effect through hippocampal cell proliferation.
Ito N; Yabe T; Gamo Y; Nagai T; Oikawa T; Yamada H; Hanawa T
Neuroscience; 2008 Dec; 157(4):720-32. PubMed ID: 18952152
[TBL] [Abstract][Full Text] [Related]
5. Kososan, a Kampo medicine, prevents a social avoidance behavior and attenuates neuroinflammation in socially defeated mice.
Ito N; Hirose E; Ishida T; Hori A; Nagai T; Kobayashi Y; Kiyohara H; Oikawa T; Hanawa T; Odaguchi H
J Neuroinflammation; 2017 May; 14(1):98. PubMed ID: 28468634
[TBL] [Abstract][Full Text] [Related]
6. Activation of orexin neurons in dorsomedial/perifornical hypothalamus and antidepressant reversal in a rodent model of depression.
Nollet M; Gaillard P; Minier F; Tanti A; Belzung C; Leman S
Neuropharmacology; 2011; 61(1-2):336-46. PubMed ID: 21530551
[TBL] [Abstract][Full Text] [Related]
7. Neurogenesis-independent antidepressant-like effects on behavior and stress axis response of a dual orexin receptor antagonist in a rodent model of depression.
Nollet M; Gaillard P; Tanti A; Girault V; Belzung C; Leman S
Neuropsychopharmacology; 2012 Sep; 37(10):2210-21. PubMed ID: 22713907
[TBL] [Abstract][Full Text] [Related]
8. Sleep disturbance associated with an enhanced orexinergic system induced by chronic treatment with paroxetine and milnacipran.
Rahmadi M; Narita M; Yamashita A; Imai S; Kuzumaki N; Suzuki T
Synapse; 2011 Jul; 65(7):652-7. PubMed ID: 21157932
[TBL] [Abstract][Full Text] [Related]
9. Milnacipran, a serotonin and norepinephrine reuptake inhibitor, induces appetite-suppressing effects without inducing hypothalamic stress responses in mice.
Nonogaki K; Nozue K; Kuboki T; Oka Y
Am J Physiol Regul Integr Comp Physiol; 2007 May; 292(5):R1775-81. PubMed ID: 17218444
[TBL] [Abstract][Full Text] [Related]
10. Effects of fluoxetine administration on neuropeptide y and orexins in obese zucker rat hypothalamus.
Gutiérrez A; Saracíbar G; Casis L; Echevarría E; Rodríguez VM; Macarulla MT; Abecia LC; Portillo MP
Obes Res; 2002 Jun; 10(6):532-40. PubMed ID: 12055330
[TBL] [Abstract][Full Text] [Related]
11. Involvement of norepinephrine and serotonin system in antidepressant-like effects of hederagenin in the rat model of unpredictable chronic mild stress-induced depression.
Liang BF; Huang F; Wang HT; Wang GH; Yuan X; Zhang MZ; Guo HB; Cheng YF; Xu JP
Pharm Biol; 2015 Mar; 53(3):368-77. PubMed ID: 25471378
[TBL] [Abstract][Full Text] [Related]
12. Electrophysiological and neurochemical characterization of the effect of repeated treatment with milnacipran on the rat serotonergic and noradrenergic systems.
Tachibana K; Matsumoto M; Koseki H; Togashi H; Kojima T; Morimoto Y; Yoshioka M
J Psychopharmacol; 2006 Jul; 20(4):562-9. PubMed ID: 16401668
[TBL] [Abstract][Full Text] [Related]
13. Three Chinese herbal medicines promote neuroproliferation in vitro, and reverse the effects of chronic mild stress on behavior, the HPA axis, and proliferation of hippocampal precursor cell in vivo.
Pao LH; Lu SW; Sun GG; Chiou SH; Ma KH
J Ethnopharmacol; 2012 Nov; 144(2):261-9. PubMed ID: 23000114
[TBL] [Abstract][Full Text] [Related]
14. Ginkgolide-Platinum(II) Complex GPt(II) Exhibits Therapeutic Effect on Depression in Mice via Upregulation of DA and 5-HT Neurotransmitters.
Yang T; Wang X; Liu L; Chen H; Wang N
Med Sci Monit; 2020 Jun; 26():e922052. PubMed ID: 32484164
[TBL] [Abstract][Full Text] [Related]
15. Preclinical pharmacology of milnacipran.
Briley M; Prost JF; Moret C
Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():9-14. PubMed ID: 8923122
[TBL] [Abstract][Full Text] [Related]
16. Milnacipran, a serotonin and noradrenaline reuptake inhibitor, suppresses long-term potentiation in the rat hippocampal CA1 field via 5-HT1A receptors and alpha 1-adrenoceptors.
Tachibana K; Matsumoto M; Togashi H; Kojima T; Morimoto Y; Kemmotsu O; Yoshioka M
Neurosci Lett; 2004 Mar; 357(2):91-4. PubMed ID: 15036582
[TBL] [Abstract][Full Text] [Related]
17. Anxiolytic-like effect of milnacipran in the four-plate test in mice: mechanism of action.
Bourin M; Masse F; Dailly E; Hascoët M
Pharmacol Biochem Behav; 2005 Jul; 81(3):645-56. PubMed ID: 15961146
[TBL] [Abstract][Full Text] [Related]
18. Acute effect of milnacipran on the relationship between the locus coeruleus noradrenergic and dorsal raphe serotonergic neuronal transmitters.
Bandoh T; Hayashi M; Ino K; Takada S; Ushizawa D; Hoshi K
Eur Neuropsychopharmacol; 2004 Dec; 14(6):471-8. PubMed ID: 15589386
[TBL] [Abstract][Full Text] [Related]
19. Effect of co-administration of a serotonin-noradrenaline reuptake inhibitor and a dopamine agonist on extracellular monoamine concentrations in rats.
Kitaichi Y; Inoue T; Izumi T; Nakagawa S; Tanaka T; Masui T; Koyama T
Eur J Pharmacol; 2008 Apr; 584(2-3):285-90. PubMed ID: 18336812
[TBL] [Abstract][Full Text] [Related]
20. JIEYUANSHEN DECOCTION EXERTS ANTIDEPRESSANT EFFECTS ON DEPRESSIVE RAT MODEL VIA REGULATING HPA AXIS AND THE LEVEL OF AMINO ACIDS NEUROTRANSMITTER.
Qiuxia Z; Xinlong M; Yilong Y; Hui Z; Yali W; Xiaoquan Y; Lei W; Jiahui C; Haiyan Z
Afr J Tradit Complement Altern Med; 2017; 14(2):33-46. PubMed ID: 28573220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
